Senseonics, Incorporated · 7 hours ago
Diabetes Therapy Associate
Senseonics, Incorporated is focused on providing innovative solutions for diabetes management, and they are seeking a Diabetes Therapy Associate to support their sales team and customers. The role involves qualifying leads, managing patient inquiries, and facilitating the shipment of the Eversense continuous glucose monitoring system to prospective patients.
Responsibilities
Work closely with a Territory Manager (TM) in your geography to qualify leads, manage patient inquiries and prospect new customers
Meet or exceed internal goals for requisitions/conversions/shipments in assigned territory
Responsible for DTC/HCP lead conversion, pipeline management, Certified Eversense Provider identification, coordination of training, patient pull through management
Discuss the benefits/costs/process of Eversense with prospective patients
Resolve customer concerns throughout the sales process from initial interest through product shipment
Complete initial and follow up calls/emails with prospective leads/opportunities via inbound and outbound contacts and track daily production via CRM
In collaboration with TM, lead field forecasting efforts in territory, ensuring that accurate forecasts are completed on a timely basis
In collaboration with Inside Sales teammate (ISR) weekly identify patient opportunities for shipment
Work in collaboration with Distributor partners to expedite shipment of patients’ Eversense CGM
Qualification
Required
Education: Bachelor's Degree or Associate's degree
3+ years of experience in medical devices or pharmaceutical Inside Sales
Possess high level understanding of US healthcare and payer landscape
High level of professionalism, customer service skills and influencing skills with the ability to problem-solve
Experience working within a CRM is a plus
Preferred
Diabetes experience preferred
Company
Senseonics, Incorporated
Senseonics, Inc.
Funding
Current Stage
Public CompanyTotal Funding
$669.3MKey Investors
Hercules CapitalAbbottPHC Holdings
2025-09-03Post Ipo Debt· $35M
2025-05-15Post Ipo Equity· $77.8M
2024-10-25Post Ipo Equity· $16M
Recent News
2026-01-13
Company data provided by crunchbase